Cochlear Limited (ASX: COH)
Australia
· Delayed Price · Currency is AUD | Market Cap | 21.64B |
| Revenue (ttm) | 2.18B |
| Net Income (ttm) | 350.40M |
| Shares Out | 65.58M |
| EPS (ttm) | 5.32 |
| PE Ratio | 62.10 |
| Forward PE | 46.30 |
| Dividend | 3.75 (1.14%) |
| Ex-Dividend Date | Mar 21, 2024 |
| Volume | 92,347 |
| Open | 336.21 |
| Previous Close | 338.90 |
| Day's Range | 330.38 - 336.63 |
| 52-Week Range | 220.40 - 350.17 |
| Beta | 0.46 |
| Analysts | n/a |
| Price Target | 283.57 (-14.17%) |
| Earnings Date | Aug 13, 2024 |
About Cochlear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia. [Read more]
Financial Performance
In 2023, Cochlear's revenue was 1.96 billion, an increase of 19.17% compared to the previous year's 1.64 billion. Earnings were 300.60 million, an increase of 3.98%.
Financial StatementsNews
How the Victorian government almost killed the next Cochlear
The Seer Medical founders created a world first, wearable device which monitored brain activity to help treat 65 million people affected by epilepsy. Where did it all go so wrong?
20 Biggest Health Care Companies in Australia, 2024
CSL Limited led the Health Care Companies listed on the Australian Securities Exchange as of March 2024, with a market capitalization of over 135.02 billion Australian dollars. Meanwhile, Cochlear Lim...
Cochlear calls for action in Washington D.C. ahead of World Hearing Day
WASHINGTON , Feb. 28, 2024 /PRNewswire/ -- Today, Cochlear assembled a team of hearing experts to emphasize the importance of hearing health for policy makers at the Australian Embassy in Washington D...
Cochlear announces 2024 winners of annual scholarships
The Graeme Clark, Anders Tjellström and Vocational Scholarships recognize exemplary leaders throughout the hearing loss community LONE TREE, Colo. , Feb. 22, 2024 /PRNewswire/ -- Eight outstanding Co...
Cochlear Limited (CHEOF) Q2 2024 Earnings Call Transcript
Cochlear’s big first half delivers best dividend in a decade
ASX COH: Cochlear’s big first half reinforces upgraded full-year guidance
ASX 200: Shares to inch towards record; Westpac, Cochlear, Ampol to report
ASX to test record atop busy week with 80 companies reporting. Follow for more.
Cochlear Ltd Adverse Appeal Decision in the US Patent Infringement Case Conference Call Transcript
Cochlear Ltd Adverse Appeal Decision in the US Patent Infringement Case Conference Call Transcript
Cochlear Ltd Annual Shareholders Meeting Transcript
Cochlear Ltd Annual Shareholders Meeting Transcript
Cochlear sales grow louder despite advances in deafness drugs
Shares rocketed in the hearing implant device maker, after it lifted earnings predictions.
Sensorion Announces the Completion of Patient Inclusion in Phase 2a Clinical Trial of SENS-401 for Residual Hearing Preservation After Cochlear Implantation
MONTPELLIER, France--(BUSINESS WIRE)--Sensorion Announces Completion of Patient Inclusion in Ph2a Clinical Trial of SENS-401 for Residual Hearing Preservation After Cochlear Implantation.
Cochlear and TechSee Win Silver in the 13th Annual Best in Biz Awards 2023
Using visual support technology powered by TechSee, Cochlear has been able to bolster their customer experience by focusing on the needs of recipients through the use of Augmented Reality. NEW YORK , ...
KEM hospital’s ‘Big Ears’ dept to host graduation programme on Dec 15
Cochlear implant programme helps integrate 178 children into mainstream
Cochlear sticks to profit guidance
The boss of bionic ear implant company Cochlear has reiterated the strong underlying growth engines of significant, unmet and addressable clinical need for cochlear and acoustic implants that should u...
Cochlear™ Osia® System becomes industry's first active bone conduction system to enable MRI at 3 Tesla
The new Osia® System with Osia OSI300 Implant enables patients to undergo MRI at 3.0 Tesla (T) without the need for surgery This has been made possible by the OSI300's unique Piezo Power™ technology a...
China and India are very important markets for Cochlear: CEO
Dig Howitt, CEO and President of Cochlear, shares the company's growth strategy in Asia.
Australia's Cochlear hits 3-month high on strong annual earnings
Shares in Cochlear hit a more than three-month high on Tuesday after the Australian hearing implant maker posted a 4% jump in full-year profit as a pandemic-fuelled backlog of surgeries cleared during...
Cochlear announces 2023 winners of annual scholarships
The Graeme Clark, Anders Tjellström and new Vocational Scholarships recognize exemplary leaders throughout the hearing loss community LONE TREE, Colo. , Feb. 24, 2023 /PRNewswire/ -- Cochlear Limited...
Cochlear announces audio streaming from Amazon Fire TV devices for hearing implant users
Cochlear further supports Audio Streaming for Hearing Aids (ASHA) standard to enable direct streaming from Fire TV devices to a Cochlear™ hearing implant for the first time. LONE TREE, Colo.
FDA approves Cochlear's Nucleus 8 Sound Processor, smaller, smarter, better connected cochlear implant technology
The Nucleus 8 Sound Processor is the world's first cochlear implant sound processor ready for Bluetooth LE Audio technology LONE TREE, Colo. , Nov. 1, 2022 /PRNewswire/ -- Cochlear Limited (ASX: COH),...
Sensorion Announces First Patient Enrolled in Proof-of-Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
MONTPELLIER, France--(BUSINESS WIRE)--Sensorion announces first patient enrolled in proof-of-concept clinical trial of SENS-401 for residual hearing preservation during cochlear implant
Cochlear expects more uncertainty due to operating room constraints: CEO
Cochlear's Dig Howitt says the hearing device implant maker is seeing cost pressures, but is planning more investment in the second half of its fiscal year.
Cochlear announces 2022 winners of annual scholarships
LONE TREE, Colo. , Feb. 2, 2022 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 20th annual Graeme Clark and the 11t...
FDA approves Cochlear Nucleus Implants for unilateral hearing loss/single-sided deafness
LONE TREE, Colo., Jan. 11, 2022 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ ...
Cochlear announces FDA approval and FDA clearance of first-of-its-kind Remote Care capabilities for Nucleus and Baha Systems
LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance...